171 related articles for article (PubMed ID: 12743607)
1. E mu/S mu transposition into Myc is sometimes a precursor for T(12;15) translocation in mouse B cells.
Kovalchuk AL; Kim JS; Janz S
Oncogene; 2003 May; 22(18):2842-50. PubMed ID: 12743607
[TBL] [Abstract][Full Text] [Related]
2. Deletional remodeling of c-myc-deregulating chromosomal translocations.
Kovalchuk AL; Müller JR; Janz S
Oncogene; 1997 Nov; 15(19):2369-77. PubMed ID: 9393881
[TBL] [Abstract][Full Text] [Related]
3. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma.
Shaughnessy J; Wiener F; Huppi K; Mushinski JF; Potter M
Oncogene; 1994 Jan; 9(1):247-53. PubMed ID: 8302586
[TBL] [Abstract][Full Text] [Related]
4. Genetic recombinations between c-myc and Igh mu as precursors for recombinations between c-myc and Igh alpha in BALB/c plasmacytomas.
Janz S; Kovalchuk AL; Müller JR; Potter M
Curr Top Microbiol Immunol; 1997; 224():241-50. PubMed ID: 9308247
[TBL] [Abstract][Full Text] [Related]
5. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.
Silva S; Wiener F; Klein G; Janz S
Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495
[TBL] [Abstract][Full Text] [Related]
6. Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation.
McNeil N; Kim JS; Ried T; Janz S
Genes Chromosomes Cancer; 2005 Jun; 43(2):137-46. PubMed ID: 15751044
[TBL] [Abstract][Full Text] [Related]
7. Generation of switch hybrid DNA between Ig heavy chain-mu and downstream switch regions in B lymphocytes.
Müller JR; Giese T; Henry DL; Mushinski JF; Marcu KB
J Immunol; 1998 Aug; 161(3):1354-62. PubMed ID: 9686598
[TBL] [Abstract][Full Text] [Related]
8. Myc translocations in B cell and plasma cell neoplasms.
Janz S
DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
[TBL] [Abstract][Full Text] [Related]
9. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M
Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044
[TBL] [Abstract][Full Text] [Related]
10. AID and Igh switch region-Myc chromosomal translocations.
Unniraman S; Schatz DG
DNA Repair (Amst); 2006 Sep; 5(9-10):1259-64. PubMed ID: 16784901
[TBL] [Abstract][Full Text] [Related]
11. AID is required for c-myc/IgH chromosome translocations in vivo.
Ramiro AR; Jankovic M; Eisenreich T; Difilippantonio S; Chen-Kiang S; Muramatsu M; Honjo T; Nussenzweig A; Nussenzweig MC
Cell; 2004 Aug; 118(4):431-8. PubMed ID: 15315756
[TBL] [Abstract][Full Text] [Related]
12. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
[TBL] [Abstract][Full Text] [Related]
13. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
14. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
Fenton JA; Pratt G; Rawstron AC; Sibley K; Rothwell D; Yates Z; Dring A; Richards SJ; Ashcroft AJ; Davies FE; Owen RG; Child JA; Morgan GJ
Oncogene; 2003 Feb; 22(7):1103-13. PubMed ID: 12592397
[TBL] [Abstract][Full Text] [Related]
15. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
Wang Y; Sugiyama H; Axelson H; Panda CK; Babonits M; Ma A; Steinberg JM; Alt FW; Klein G; Wiener F
Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720
[TBL] [Abstract][Full Text] [Related]
16. Two antisense promoters in the immunoglobulin mu-switch region drive expression of c-myc in the Burkitt's lymphoma cell line BL67.
Apel TW; Mautner J; Polack A; Bornkamm GW; Eick D
Oncogene; 1992 Jul; 7(7):1267-71. PubMed ID: 1620543
[TBL] [Abstract][Full Text] [Related]
17. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
Jain VK; Judde JG; Max EE; Magrath IT
J Immunol; 1993 Jun; 150(12):5418-28. PubMed ID: 8515068
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin/Myc recombinations in murine Peyer's patch follicles.
Müller JR; Mushinski EB; Williams JA; Hausner PF
Genes Chromosomes Cancer; 1997 Sep; 20(1):1-8. PubMed ID: 9290947
[TBL] [Abstract][Full Text] [Related]
19. Plasma cell tumour progression in iMycEmu gene-insertion mice.
Kim JS; Han SS; Park SS; McNeil N; Janz S
J Pathol; 2006 May; 209(1):44-55. PubMed ID: 16482495
[TBL] [Abstract][Full Text] [Related]
20. C-myc-S mu rearrangement in a murine plasmacytoma without visible chromosomal translocations.
Ohno S; Migita S; Murakami S
Oncogene; 1989 Dec; 4(12):1513-7. PubMed ID: 2687771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
